Efficacy and Safety of Oral Roflumilast Taken With Low Dose Inhaled Corticosteroids in Patients With Asthma (12 to 70 y) (BY217/M2-013)

NCT00163527 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2054

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Roflumilast

Sponsor

AstraZeneca

Collaborators

[object Object]